4//SEC Filing
CATHERS BRIAN EDWIN 4
Accession 0000899243-21-004734
CIK 0001629137other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:28 PM ET
Size
11.0 KB
Accession
0000899243-21-004734
Insider Transaction Report
Form 4
CATHERS BRIAN EDWIN
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2021-02-01+3,020→ 10,730 total - Tax Payment
Common Stock
2021-02-01$49.49/sh−1,178$58,299→ 9,552 total - Award
Common Stock
2021-02-01$41.17/sh+267$10,992→ 7,710 total - Exercise/Conversion
Restricted Stock Units
2021-02-01−3,020→ 18,120 total→ Common Stock (3,020 underlying)
Footnotes (4)
- [F1]Shares acquired pursuant to the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]Represents number of shares of Issuer's Common Stock sold to satisfy the Reporting Person's tax obligations in connection with the vesting of 3,020 shares of Common Stock underlying the Reporting Person's RSUs.
- [F4]The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2020, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
Documents
Issuer
Global Blood Therapeutics, Inc.
CIK 0001629137
Entity typeother
Related Parties
1- filerCIK 0001769127
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 6:28 PM ET
- Size
- 11.0 KB